Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of combination of docetaxel,
oxaliplatin, and S-1 (DOS) in the treatment of advanced gastric cancer.